These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37178589)

  • 1. Microphysiological head and neck cancer model identifies novel role of lymphatically secreted monocyte migration inhibitory factor in cancer cell migration and metabolism.
    Yada RC; Desa DE; Gillette AA; Bartels E; Harari PM; Skala MC; Beebe DJ; Kerr SC
    Biomaterials; 2023 Jul; 298():122136. PubMed ID: 37178589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
    Dumitru CA; Gholaman H; Trellakis S; Bruderek K; Dominas N; Gu X; Bankfalvi A; Whiteside TL; Lang S; Brandau S
    Int J Cancer; 2011 Aug; 129(4):859-69. PubMed ID: 21328346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
    Kindt N; Preillon J; Kaltner H; Gabius HJ; Chevalier D; Rodriguez A; Johnson BD; Megalizzi V; Decaestecker C; Laurent G; Saussez S
    J Cancer Res Clin Oncol; 2013 May; 139(5):727-37. PubMed ID: 23354841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay between tumor and nodal microenvironments for the formation of nodal premetastatic niche in head and neck cancer.
    Mastronikolis NS; Spyropoulou D; Kyrodimos E; Piperigkou Z; Giotakis E; Delides A; Karamanos NK
    Am J Physiol Cell Physiol; 2023 Dec; 325(6):C1516-C1531. PubMed ID: 37927238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropilin-2 acts a critical determinant for epithelial-to-mesenchymal transition and aggressive behaviors of human head and neck cancer.
    Ahn MH; Kim JH; Choi SJ; Kim HJ; Park DG; Oh KY; Yoon HJ; Hong SD; Lee JI; Shin JA; Cho SD
    Cell Oncol (Dordr); 2024 Apr; 47(2):497-511. PubMed ID: 37787967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis.
    Hagemann T; Robinson SC; Thompson RG; Charles K; Kulbe H; Balkwill FR
    Mol Cancer Ther; 2007 Jul; 6(7):1993-2002. PubMed ID: 17620429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains.
    Saussez S; Laumbacher B; Chantrain G; Rodriguez A; Gu S; Wank R; Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1007-27. PubMed ID: 25030361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
    Prasad M; Zorea J; Jagadeeshan S; Shnerb AB; Mathukkada S; Bouaoud J; Michon L; Novoplansky O; Badarni M; Cohen L; Yegodayev KM; Tzadok S; Rotblat B; Brezina L; Mock A; Karabajakian A; Fayette J; Cohen I; Cooks T; Allon I; Dimitstein O; Joshua B; Kong D; Voronov E; Scaltriti M; Carmi Y; Conde-Lopez C; Hess J; Kurth I; Morris LGT; Saintigny P; Elkabets M
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35292516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
    Wang SS; Cen X; Liang XH; Tang YL
    Oncotarget; 2017 Feb; 8(6):10650-10661. PubMed ID: 27788497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
    Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
    Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment.
    Prieto-Fernández L; Montoro-Jiménez I; de Luxan-Delgado B; Otero-Rosales M; Rodrigo JP; Calvo F; García-Pedrero JM; Álvarez-Teijeiro S
    Biomed Pharmacother; 2023 May; 161():114502. PubMed ID: 37002578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
    Otvos B; Silver DJ; Mulkearns-Hubert EE; Alvarado AG; Turaga SM; Sorensen MD; Rayman P; Flavahan WA; Hale JS; Stoltz K; Sinyuk M; Wu Q; Jarrar A; Kim SH; Fox PL; Nakano I; Rich JN; Ransohoff RM; Finke J; Kristensen BW; Vogelbaum MA; Lathia JD
    Stem Cells; 2016 Aug; 34(8):2026-39. PubMed ID: 27145382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment.
    Simons D; Grieb G; Hristov M; Pallua N; Weber C; Bernhagen J; Steffens G
    J Cell Mol Med; 2011 Mar; 15(3):668-78. PubMed ID: 20178462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell RNA sequencing reveals the MIF-ACKR3 receptor-ligand interaction between iCAFs and tumor cells in esophageal squamous cell carcinoma.
    Liang J; Lei K; Liang R; Huang J; Tan B; Lin H; Wang M
    Cell Signal; 2024 May; 117():111093. PubMed ID: 38336189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autofluorescence Imaging of 3D Tumor-Macrophage Microscale Cultures Resolves Spatial and Temporal Dynamics of Macrophage Metabolism.
    Heaster TM; Humayun M; Yu J; Beebe DJ; Skala MC
    Cancer Res; 2020 Dec; 80(23):5408-5423. PubMed ID: 33093167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Head and Neck Cancer Pain.
    Ye Y; Jensen DD; Viet CT; Pan HL; Campana WM; Amit M; Boada MD
    J Dent Res; 2022 Aug; 101(9):1025-1033. PubMed ID: 35416080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFβ3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis.
    Qin X; Yan M; Zhang J; Wang X; Shen Z; Lv Z; Li Z; Wei W; Chen W
    Sci Rep; 2016 Feb; 6():20587. PubMed ID: 26857387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLAU promotes cell proliferation and migration of head and neck cancer via STAT3 signaling pathway.
    Cui X; Sun H; Liu X; Bai Y; Bai Y; Cui Y; Wang B; Zhang S; Li X
    Exp Cell Res; 2024 May; 438(2):114056. PubMed ID: 38663475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell RNA sequencing reveals aberrant sphingolipid metabolism in non-small cell lung cancer impacts tumor-associated macrophages and stimulates angiogenesis via macrophage inhibitory factor signaling.
    Shen L; Liu J; Hu F; Fang Y; Wu Y; Zhao W; Ma S
    Thorac Cancer; 2024 May; 15(14):1164-1175. PubMed ID: 38587042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.